Skip to main content
. 1998 Feb 17;95(4):1725–1729. doi: 10.1073/pnas.95.4.1725

Table 1.

Effect of anti-RANTES, MIP-1α, and MIP-1β neutralizing antibodies on the ability of CD8+ cells to suppress HIV replication when separated from the infected Mφ by a transwell insert

Exp. GM-CSF CD8+ cells* Treatment RANTES, pg/ml MIP-1α, pg/ml MIP-1β, pg/ml RT activity, ×10−3 cpm/ml
1 No antibody <5 681 796 533.6
 + No antibody <5 87.5 115.2 130.5
+ Control antibody§ 247.1 269 220 158.1
+ anti-β-chemokine antibody <5 <6 14.6 102.4
2 No antibody <5 964.2 1453 729.1
+ No antibody 25.7 201 26.6 186.5
+ Control antibody 26.5 571.7 714.8 72.7
+ anti-β-chemokine antibody <5 <6 <4 152.8
3 + No antibody <5 180.4 27.1 1305.0
+ + No antibody 126.9 190.4 114.1 267.1
+ + anti-β-chemokine antibody <5 6.4 6.1 99.0
*

Separated from macrophages by a transwell insert (0.45 μm pore size filter). 

β-chemokine levels were determined by RANTES, MIP-1α, and MIP-1β specific ELISA. 

The level of RANTES, MIP-1α, and MIP-1β in the culture fluid of CD8+ cells in the absence of infected macrophages was 249.5, 24.9, and 20.3 pg/ml, respectively. 

§

250 μg/ml of normal goat IgG. 

100 μg/ml of anti-RANTES, 50 μg/ml of anti-MIP-1α, and 100 μg/ml of anti-MIP-1β polyclonal goat antibodies.